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In most patients with type 2 diabetes, along with the presence of disturbances of 
glycemic control, there are disturbances of lipid metabolism and elevated blood 
pressure, which are strong risk factors for the development of late, especially 
macrovascular complications and whose base is the vulnerable atherosclerotic plaque. 
This study included a total of 101 individuals (51 patients suffering from diabetes 
mellitus type 2-DMT2 and 50 healthy subjects). Distribution of respondents according to 
the presence of hyperlipoproteinaemia, vulnerable and invulnerable atherosclerotic 
plaque was done. The data were analyzed by appropriate statistical tests. 
Hyperlipidaemia was more prevalent in patients with DMT2 than in the control ones 
(p<0.05). Cholesterol levels were significantly higher (p<0.05) in subjects with DMT2 
(5.74±2.69 vs. 4.82±1.11mmol/L) as well as triglycerides (1.94±2.2 compared to 
1.6±1.14mmol/L) (p<0.001). Mean values of glucose in the group of subjects with 
diabetes mellitus type 2 (10.54±3.75mmol/L) and in the control group (4.53±2.14mmol/L) 
were significantly different (p<0.001). Glycosylated hemoglobin HbA1c was significantly 
higher in patients with DMT2 (9.30±2.26%) than control group (4.98±0.05%). Mean 
values of both systolic and diastolic blood pressure were significantly higher in subjects 
with diabetes mellitus type 2 (149.55±29.27mmHg and 87.92±17.58mmHg) compared 
to those in the control group (mean systolic blood pressure of 128.32±25.77 and mean 
diastolic blood pressure 79.11±9.51mmHg). Plaque was found in 100% of diabetic 
patients, as opposed to 28.12% of patients in the control group. Vulnerable plaque was 
found in 47.06% of patients in the group with type 2 diabetes and 6.25% in the control 
group. Analysis with the Mann-Whitney-test shows that the incidence of plaque and 
vulnerable plaque was significantly higher in DMT2 patients (p<0.001). 
Hyperlipidaemia, hypertension and type 2 diabetes mellitus are significantly 
associated with atherosclerotic changes in the blood vessels. Ultrasound determination 
of plaque vulnerability in the carotid arteries is one of the most important criteria for the 
classification of patients at high risk for ischemic stroke and development of DMT2. Acta 
Medica Medianae 2012;51(3):29-37. 
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Introduction 
 
Diabetes, especially type 2, is a global 
problem of modern age due to a marked increase 
in prevalence up to pandemic proportions, but also 
due to vascular complications. It is believed that 
over 60% of diabetics die from cardiovascular 
complications and that the mortality from 
myocardial infarction and stroke  is 2  to 4 times 
higher (1). 
In diabetes, there is a concurrence of 
several independent risk factors for cardiovascular 
complications. Some risk factors appear associated 
with diabetes, others are some of the compli-
cations of diabetes and the third ones are the 
result of lifestyle and habits. Traditional risk 
factors, such as dyslipidaemia (high triglycerides 
and low density lipoprotein (LDL cholesterol) and 
reduced levels of high density lipoprotein (HDL 
cholesterol), hypertension and obesity, cannot 
fully explain an excessive risk for vascular 
disease in diabetes, and the role of "non-traditi-
onal" risk factors can be extremely important 
(insulin resistance, endothelial dysfunction, hyper-
fibrinolysis, inflammation, microalbuminuria). It is 
clear that we should not forget genetics as a risk 
factor and lifestyle (smoking, physical activity) 
(2,3). In addition, we should note some bio-
chemical factors which are increased in patients 
with diabetes and have influence on athero-
sclerosis, or can be the indicators of an acute 
phase, e.g.CRP (C-reactive protein), Interleucin 
6, fibrinogen, TNF alpha (tumor necrosis factor), 
PAI (plasminogen activator inhibitor) (2,3). In the 
recent years, Lp-PLA2 (Lipoprotein-associated 
phospholipase A2) has been in the focus of Relationships between metabolic parameters and plaque...                                                                            Muamer Suljić et al. 
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interest, because it can point to an inflammatory 
process in the vascular system. 
Hyperlipidaemias pose one and some say 
the most important risk factor for the develop-
ment of vascular diseases and atheroclerosis. 
Previous investigations have shown not only the 
quantitative but also the qualitative lipid dis-
orders in type 2 diabetes, so that the term 
dyslipidemia is being increasingly used.  Dyslipi-
demia occurs in 70-97% of all people with 
diabetes (4). Dislipidaemia is particularly common 
in type 2, either as a primary, the associated 
disorder (within the metabolic syndrome), or as a 
secondary phenomenon, due to  poor  glycaemic 
control (5).  
High blood pressure (greater than 130/ 
80mmHg) affects roughly 60-70% of people with 
diabetes, depending on their age, obesity and 
ethnicity. Hypertension is important because it 
represents a major growth factor of risk for the 
vascular diseases and it works synergistically 
with diabetes or hyperglycaemia (6). 
As in the majority of patients with type 2 
diabetes, along with the presence of disturbance 
of glycemic control, there are disturbances of 
lipoprotein and elevated arterial pressure, the 
modern treatment of this disease should necessarily 
implement a comprehensive approach, such as a 
good metabolic control, where both glycemic 
control and disorders of lipoprotein metabolism 
and elevated arterial pressure are corrected. In 
this sense, the target serum glucose, HbA1c and 
lipoprotein levels are defined by the level of 
vascular risk to which they correspond. Accor-
dingly, HbA1c values equal to or less than 6.5%, 
morning glucose equal or less than 5.5 mmol/L, 
total cholesterol less than 4.8 mmol/L and   
triglycerides less than 1.7mmol/L are the values 
of low risk for vascular complications. Patients 
with the values above optimal are at risk for 
macrovascular and microvascular complications. 
In accordance with modern recommendations, 
there is a vascular risk for complications if blood 
pressure is over 130/80mmHg (7). 
 
Morphological characteristics of  athero-
sclerotic  plaque 
 
The basic histopathological substrate of 
vascular complications in diabetes mellitus is 
atherosclerotic plaque, and therefore, an adequate 
treatment of patients with vascular disease is 
conditioned by timely and precise diagnosis. 
Ultrasonography is a sovereign method 
among angiographic methods for the assessment 
of carotid  atherosclerotic plaque. It provides not 
only the quantitative analysis of plaque (length, 
width, thickness, degree of lumen stenosis), but 
also  the qualitative  analysis of plaque structure, 
plaque area and presence of thrombus. Plaque is 
defined as intraluminal focal prominence 1,4mm 
or more in length and 5mm or more in extent. By 
Color doppler ultrasound examination on longi-
tudinal section, first we determined plaque locali-
zation on carotid artery and its length, then  on 
the cross section we determined its position. 
Further, we assessed the plaque structure based 
on ultrasound density and edges of the plaque, 
and in the end we estimated the extent of 
stenosis based on maximal speed in the systole. 
According to this quality score system, 
plaque can be: 
Type 1: hypoehogenic and homogenic, 
corresponds to lipid plaque; 
Type 2: entirely hypoehogenic but with 
heterogenic distribution echo, and more than 
50% hypoehogenic elements, corresponds to 
lipid/fibrotic plaque. 
Type 3: entirely hyperehogenic, but with 
heterogenic distribution echo, and more than 
50% of hyperehogenic elements, corresponds to 
lipid/fibrotic plaque. 
Type 4: hyperehogenic and homogenic, 
corresponds to fibrotic plaque. 
Type 5: calcified plaque which has acoustic 
scattering shadow. Based on this analysis, the 
“danger” of the plaque for the occurrence of 
cerebrovascular disease can be estimated and 
whether there is an indication for surgical 
removal (endarterectomy)  (8). 
Division of plaques that have clinical 
implications is the division into the vulnerable   
(complicated, unstable) and invulnerable  (uncompli-
cated, stable). Vulnerable plaques are those in 
which the exulcerated surface (ulceration in an 
area where  there has been a separation of lipid 
plaque) or where there is vascular wall throm-
bosis (hypoechogenic structure of appositional 
thrombus) or hemorrhage in the plaque (anecho-
genic centre of plaque). These plaques are 
unstable, their parts tend to separate, with the 
possibility of distal embolization of the arteries. 
Hypoehogenic plaque (lipid) is vulnerable, its 
content can easily get into blood and react as 
procoagulant, making thrombus. This plaques are 
dangerous, unstable and can cause cerebro-
vascular diseases  (8,9). 
 
Aims 
 
1. To determine the difference in the 
presence of hyperlipidaemia and hypertension 
among patients with type 2 diabetes mellitus and 
healthy control subjects. 
2. To examine the dependence of hyper-
lipidaemia, hypertension and hyperglycaemia and 
atherosclerotic plaque vulnerability. 
3. To determine the frequency of occurrence 
of atherosclerotic plaques in the carotid arteries 
in patients with type 2 diabetes mellitus compared 
to healthy subjects. 
 
Examinees and methods 
 
This prospective study analyzed  a total of 
101 subjects, male and female. 
All subjects were divided into two test 
groups - group 1 patients with overt diabetes mellitus Acta Medica Medianae 2012, Vol.51(3)                                                  Relationships between metabolic parameters and plaque... 
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type 2 (n=51), and group 2 - control group of 
healthy subjects (n=50). 
According to the gender, the first group 
was composed of 25 males (49%) and 26 
females (51%). In the second group there were 
24 males (48%) and 26 females (52%). 
Diabetes mellitus was diagnosed  based on 
the fasting glucose above 7mmol/L, verified  on 
at least two occasions, i.e. on the basis of clinical 
documentation and the OGTT test. Blood glucose 
concentration was determined by photometric 
analysis, the GOD-PAP method with the reference 
value of 3.6 to 6.1mmol/L. The values of glyco-
sylated hemoglobin, HbA1c was assessed electro-
phoretically (Isolab techniques) as a percentage 
of total hemoglobin. The values between 4.2 % 
and 6.2% are taken for the standard ones. 
Testing vulnerability of atherosclerotic plaques 
of carotid arteries by ultrasound was performed 
on the equipment Toshiba Cori Vision Pro (Japan, 
2002.), based on the echogenicity of plaque, its 
global appearance, homogeneity, size, regularity 
of the edge and clarity of the fibrous cap. The 
criteria for vulnerable plaque are: homogenic 
hypoechogenicity (lipid plaque), trombolisis by 
the wall (hypoechogenic structure of appositional 
thrombus), haemorrhage in plaque (anehogenic 
midpoint of plaque) and exulceration plaque 
surface (ulceration on places where separation of 
plaque occurs). 
Cholesterol in the plasma was determined 
by colour enzyme PAP method. Reference values 
were 3.63-6.7mmol/L. Triglycerides in the plasma 
w e r e  i n v e s t i g a t e d  b y  c o l o u r  e n z y m e  E S P A  -  S  
method, with the standard values in the range 
1.7-2.3mmol. The criteria for vulnerable plaque 
are: homogenic hypoechogenicity (lipid plaque), 
trombolisis by the wall (hypoechogenic structure 
of appositional thrombus), haemorrhage in plaque 
(anehogenic midpoint of plaque) and exulceration 
plaque surface (ulceration on places where 
separation of plaque occurs). 
The values of arterial blood pressure were 
obtained by using  sphingomanometer according 
to the standard procedure. 
Distribution of respondents by the presence 
of certain measured parameters – hyperlipo-
proteinaemia, hypertension and the presence of 
vulnerable and invulnerable atherosclerotic plaque 
is presented in percentage. Results of statistical 
comparisons obtained by Student’s t-test and 
Mann-Whitney test are shown in the diagram. 
The results of correlation analysis are presented 
with corresponding tables, with a statistically 
significant correlation. 
 
Results 
 
Regarding the age, the average age of 
patients in the group of patients with diabetes 
mellitus type 2 was 62.42±10.14 years. In the 
control group, it was 57.63±12.12 years. The 
average age of patients in the control and study 
group were not significantly different (p>0.05). 
Mean values of glucose in the group of subjects 
with diabetes mellitus type 2 (10:54±3.75 mmol/L) 
and in the control group (4.53±2.14mmol/L) are 
statistically significantly different (p<0.001). 
Analyzing the mean glycosylated hemoglobin 
HbA1c, it can be seen that the highest values of 
this laboratory parameter is in the group of 
patients with diabetes mellitus (9.30±2.26%) and 
in comparison to the control group (4.98±0.05%) 
the difference is statistically significant. In the 
investigated group, 65% patients were on peroral 
antidiabetic drugs and 35% on insulin therapy. 
Hyperlipidemia, regardless of the type of 
disorder, was far more frequent in patients  with 
diabetes mellitus type 2 than in the control 
group. Normal values of serum lipids  were found 
in the majority (71.87%) of subjects in the 
control group and the minority (49.12%) of 
patients with diabetes. Lipid abnormalities were 
observed in 50.98% of patients with type 2 
diabetes mellitus, as well as 28.13% in the 
control group. The difference, according to the 
results of Mann-Whitney's test of distribution by 
the presence of hyperlipidaemia, was statistically  
significant  (p <0.05)  (Figure 1).  
The mean values of total cholesterol and 
triglycerides in the group of  patients  with type 2 
diabetes mellitus and the control group are 
shown in Figures 1 and 2. Cholesterol levels in 
the blood were significantly higher (p <0.05) in 
patients with type 2 diabetes mellitus (5.74±2.69 
compared to 4.82±1.11mmol/L). The difference 
in the mean level of triglycerides in the blood 
between these two groups (1.94±2.2 compared 
to 14.1±1.6mmol/L) was even more pronounced 
(p<0.001)). 
Mean values of both systolic and diastolic 
blood pressure were significantly higher in 
subjects with diabetes mellitus type 2 (149.55± 
29.27mmHg and 87.92±17.58mmHg) compared 
to those in the control group (mean systolic blood 
pressure of 128.32±25.77mmHg and mean 
diastolic blood pressure 79.11±9.51mmHg). 
Student's t-test for small independent samples 
proved that the difference in both systolic and 
diastolic arterial blood pressure was statistically 
significant, with a value of p <0.001 (Figure 2). 
The distribution of patients according to the 
presence and type of atherosclerotic plaque in 
the carotid arteries in the study and control 
groups are shown in Figures 4 and 5. Plaque was 
found in 100% of diabetic patients versus 28.12% 
of patients in the control group. Vulnerable plaque 
was found in 47.06% of patients with type 2 
diabetes and 6.25% in the control group. Analysis 
of the Mann-Whitney-MAOIs test showed that the 
difference in the incidence of plaque and plaque 
vulnerability are highly statistically significant (p 
<0.001). 
Hyperlipidemia, hypertension, serum glucose 
level and duration of diabetes were significantly 
correlated with the presence of atherosclerotic 
plaque vulnerability (Table 1). Vulnerability of 
atherosclerotic plaque significantly correlates 
with hypertension, hyperlipidemia and glucose 
value (Table 1). Also, in Tables 2,3 and 4, statistically Relationships between metabolic parameters and plaque...                                                                            Muamer Suljić et al. 
significant correlation between glucose value, hyper-
lipidemia and hipertension is shown, with plaque 
vulnerability on carotid artery. In Table 5, stati-
stically significant correlation between diabetes 
mellitus and plaque vulnerability can be seen.  
Although dyslipidaemia is a well-known risk 
factor for atherosclerosis and coronary heart 
disease, only the more recent studies with statins 
have clearly indicated that abnormalities of 
serum lipids increase the risk of acute ischemic 
stroke (AIS). People with diabetes are more 
prone to changes in lipid status in comparison 
with the general population (elevated triglycerides, 
low HDL cholesterol, high LDL cholesterol). The 
knowledge of the positive effects of lowering 
cholesterol on the risk of acute ischemic stroke in 
diabetic patients are derived in the majority of 
cases from the studies with patients who have a 
coronary disease.  
 
Discussion  
 
Nowadays, 200 million people in the world 
suffer from diabetes, in our country over 500,000. 
Over 90% of all patients s u f f e r  f r o m  t y p e  2  
diabetes. The number of cases is increasing, life 
expectancy is extended, which increases the 
incidence of late complications of diabetes.  
 
 
Figure 1. Distribution by the presence of  hyperlipoproteinemia in the group  of patients with diabetes mellitus 
type 2 and control group 
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Figure 2. Mean values of systolic and diastolic blood pressure in the patients with type 2 diabetes mellitus and 
control group 
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Figure 3. Distribution by the presence and classes of plaque in the group of patients with diabetes mellitus type 2 
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Figure 4. Distribution by the presence and classes of plaque in control group 
 
Table 1. Statistically significant correlation between atherosclerotic plaque vulnerability and relevant research 
parameters 
 
 
Spearman’s correlation 
coefficient 
Statistical significance 
Age 0,738  p<0,0001 
Presence of diebetes  0.709  p<0,0001 
Glycemia 0,692  p<0,0001 
HbA1C 0,651  p<0,0001 
Presence of hyperlipoproteinemia  0,164  p<0,01 
Presence of hypertension  0,477  p<0,0001 
 
Table 2. Statistically significant correlation between glycemia value and relevant research 
 
 
Spearman’s correlation 
coefficient 
Statistical significance 
Age 0,988  p<0,0001 
Presence of hypertension  0,242  p<0,045 
Plaque vulnerability  0,692  p<0,0001 
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Table 3. Statistically significant correlation between presence of hypertension and relevant research  
parameters 
 
 
Spearman’s correlation 
coefficient 
Statistical significance 
Age -0,386  p<0,001 
Presence of diebetes  0.54  p<0,0001 
Glycemia 0,242  p<0,045 
HbA1C 0,292  p<0,007 
Presence of hyperlipoproteinemia  0,279  p<0,006 
Presence of hypertension  0,477  p<0,0001 
 
Table 4. Statistically significant correlation between presence of hyperlipoproteinemia and relevant  research  
parameters 
 
 
Spearman’s correlation 
coefficient 
Statistical significance 
Age 0,235  p<0,017 
Presence of hypertension  0,279  p<0,006 
Plaque vulnerability  0,364  p<0,01 
 
Table 5. Statistically significant correlation between presence of diabetes mellitus  and relevant  research  
parameters 
 
 
Spearman’s correlation 
coefficient 
Statistical significance 
Age 0,565  p<0,0001 
Presence of hyperlipoproteinemia  0,235  p<0,02 
Presence of hypertension  0,54  p<0,0001 
Plaque vulnerability  0,709  p<0,0001 
 
 
The results of a recent study (Long Term 
With Intervention With Pravastatin in Ischemic 
Disease Trial) with about 2.000 patients with 
coronary disease, who had DM or glucose 
intolerance, have shown that statin therapy 
lowers the risk of cardiovascular disease (CVD) 
and acute ischemic stroke. United HPS study 
(Heart Protection Study) in which simvastatin 
was used for cholesterol lowering has given the 
evidence of the efficacy of this treatment in the 
prevention of CVD and CVA. The patients with 
CVD and earlier acute ischemic stroke were 
under great risk of future vascular events and 
had the greatest benefit from taking statins. It is 
recommended that the statins are used routinely 
in primary and secondary prevention of acute 
ischemic stroke in diabetic patients, regardless of 
initial cholesterol values (10). The positive effect 
of statins is beyond their hypolipaemic effect, 
which is explained by non-lipid protective mecha-
nisms such as plaque stabilization, recovery of 
endothel and anti-inflammatory effect.  
The results of CARDS study (Collaborative 
Atorvastatin Diabetes Study) contribute to the 
effectiveness of statins in primary prevention of 
acute ischemic stroke in patients with DM. 
Suffering from acute ischemic stroke was lower 
by 48% in patients who received atorvastatin 
(10mg/dan) compared to the placebo group, with 
a total of 2.838 patients with type 2 DM (11). 
ASCOT (Anglo Scandinavian Cardiac Out-
comes Trial) study showed that the patients with 
high levels of blood pressure and normal 
cholesterol levels have a significant improvement 
during treatment with atorvastatin at the dose of 
10 mg per day. The results showed that even 
before the deadline for completion of the study, 
the groups of subjects who took statins had a 
36% reduction in heart attack and stroke than 
the control group (12). 
MIRACL (Effect of Atrovastatin on early 
ischemic events in recurrent acute coronary 
syndromes) study showed that the early use of 
atorvastatin in acute coronary syndrome reduced 
the incidence of adverse ischemic events and 
reduced significantly the occurrence of cerebral 
infarction (50%)(17). ASAP (Effect of aggressive 
versus conventional lipid lowering on athero-
sclerosis progression in familiar hypercholestero-
laemia) study is the first study that showed the 
regression of atherosclerotic plaque in the carotid 
arteries (14). 
The latest experience with intravascular 
ultrasound examination of the coronary arteries 
showed that the hypoechoic, echolucent (lipid) 
plaque is vulnerable, can easily rupture when 
atheromatous content gets into the blood, acting 
immediately procoagulantly, forming a thrombus 
and occlusion of the coronary arteries with an 
acute myocardial infarction. These hypoechoic, 
eholucent plaques, which are unstable, are seen 
and have the same importance in the carotid 
arteries (11). There was a correlation between 
the presence of hypoechogenic (echolucent) Acta Medica Medianae 2012, Vol.51(3)                                                  Relationships between metabolic parameters and plaque... 
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plaques and ischemic changes on brain CT (15). 
A longitudinal, prospective study found an 
association between hypoechogenic plaques and 
the subsequent occurrence of ischemic strokes in 
people who were asymptomatic at the time of 
ultrasound scan. The results of this study showed 
that hypoechoic plaques were a risk factor for 
stroke at the same level as the carotid stenosis of 
50% or more (11). Unregulated diabetes and 
hypercholesterolaemia usually correlate with the 
appearance of hypoechogenic plaques. Quantitative 
and qualitative analysis of the plaque should be 
finished with the evaluation of plaque stability. 
Unstable plaque is potentially emboligenic or   
thrombogenic, and is directly linked with possible 
ischemic disorders of the brain. It is essential to 
assess the surface of plaque, which can be 
regular (smooth), irregular (ragged, but conti-
nuous) and exulcerated (ulcerated, with craterous 
hollows in places where the parts of lipid 
plaque were separated). Regular and irregular 
surfaces are seen in stable plaques and exul-
cerated surface in unstable or vulnerable plaques 
(8,16). 
In the UKPDS study (United Kingdom 
Prospective Diabetes Study), 1.148 patients were 
randomized to achieve target blood pressure 
(144/82mmHg). After 9 years, patients with 
lower blood pressure achieved the 37% reduction 
in cardiovascular complications including micro-
vascular ones, stroke by 44% and heart failure 
by 56%.The subsequent results of this study 
showed that lowering systolic pressure by 
10mmHg reduces microvascular complications   
by 13% and  myocardial infarct by 11%. (17). 
HOT study (Hypertesion Optimal Treatment) 
showed that the incidence of ischemic heart 
disease and other vascular complications in 
diabetics were reduced by 50% if the diastolic 
pressure was below 80mmHg (18). 
HOPE study (Heart Outcomes Prevention 
Evaluation) showed that a large number of 
patients, treated with ramipril, had a reduction in 
cardiovascular mortality by 37%, myocardial 
infarction by 22%, stroke by 33% (19). The results 
of the largest global study on hypertension so far 
- ALLHATstudy (Antihypertesive and Lipid Lowering 
treatment to Prevent Heart Attack Trial) showed a 
significant reduction in morbidity and mortality in 
diabetic and non-diabetic patients with a 
decrease in hypertension, whereas it showed that 
new groups of antihypertensive drugs are not 
better than diuretics (20). 
The results of a meta-analysis of 38 studies 
that have examined the incidence and mortality 
due to cardiovascular diseases have shown that 
the risk for cardiovascular disease increases by 
36% in patients with elevated HbA1c. It is also 
shown that the value of fasting glucose and 
HbA1c show a correlation with the appearance of 
fatal and nonfatal stroke (21). The mechanisms 
by which glycaemic control in type 2 diabetes 
accelerates the occurrence of atherosclerosis and 
cardiovascular events are complex and inter-
twined with each other. Hyperglycaemia is the 
cause of endothelial dysfunction, which is an 
important risk factor for cardiovascular disease in 
diabetes (22). Hyperglycaemia indirectly increases 
cardiovascular risk increasing the value of tri-
glycerides, total cholesterol and LDL-cholesterol 
in serum; it is the cause of the glycation of 
lipoproteins, which become more atherogenic and 
also accelerates the oxidation of lipoproteins, the 
most important event in the pathogenesis of 
atherosclerosis (23). In IRAS study (Insulin 
Resistant Atherosclerosis Study), it was shown 
that CRP correlates not only with the appearance 
of coronary disease but it correlates with insulin 
sensitivity, glucose resistance, sex and age. Similar 
results have been obtained with interleukin 1 and 
interleukin 6. Also, PAI 1 (Plasminogen Activator 
Inhibitor) has increased in patients with diabetes 
type 2. Lp-PLA 2 (Lipoprotein-associated phospho-
lipase A2) is a specific enzyme which indicates an 
inflammatory process in the vascular system. It 
is not an indicator of systemic inflammation but 
a proatherogenic enzyme which is produced by 
macrophage and lymphocytes. Lp-PLA 2 is 
present in two forms - as interleukins which 
circulate in plasma and 80% is binded to LDL. Lp-
PLA2 indicates the  presence of plaques which 
have tendency to rupture and it is significantly 
increased when rupture occurs. Many epidemio-
logy studies have shown the association between 
high values of Lp-PLA2 and risk of cardiovascular 
disease. In ARIC (Atherosclerosis Risk in 
Communites Study), the mass of Lp-PLA2 was an 
independent risk predictor for coronary events in 
patients with valuesof LDL below the median 
(LDL-c 130mg/dl). 
 
Conclusion 
 
1. Hypertension and hyperlipidaemia, regard-
less of the type of disorder, were far more 
frequent in patients with diabetes mellitus type 2 
than in the control group. 
2. Hyperlipidaemia, hypertension, serum glucose 
level and duration of diabetes significantly 
correlated with the presence of atherosclerotic 
plaque vulnerability. 
3. The incidence of vulnerable plaques was 
significantly higher in patients with diabetes 
mellitus than in the control group of healthy 
subjects. Also, the vulnerability of atherosclerotic 
plaque on carotid artery significantly correlates 
with age, hypertension, hyperlipidemia and 
glucose value. 
4. Diabetes mellitus type 2 and the para-
meters of metabolic control were significantly 
associated with atherosclerotic changes in blood 
vessels. Ultrasound evaluation of plaque vulnera-
bility in the carotid arteries is one of the 
important criteria for classification of patients at 
high risk for ischemic stroke. Relationships between metabolic parameters and plaque...                                                                            Muamer Suljić et al. 
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POVEZANOST METABOLIČKIH PARAMETARA I VULNERABILNOSTI 
PLAKOVA NA KAROTIDNIM ARTERIJAMA KOD OSOBA OBOLELIH  OD 
DIJABTES MELITUSA TIP 2 
 
Muamer Suljić i Aleksandar Jovanović 
 
 
Kod većine bolesnika sa tipom 2 dijabetesa, uporedo sa prisustvom poremećaja 
glikoregulacije postoje i poremećaji metabolizma lipida i povišen arterijski krvni pritisak 
koji predstavljaju snažne faktore rizika za razvoj kasnih, posebno makrovaskularnih 
komplikacija, a u čijoj osnovi je vulnerabilni aterosklerotski plak.  
U ispitivanju je učestvovala 101 osoba (51 sa dijabetes melitusom tip 2-DMT2 i 
50 zdravih ispitanika). Bolesnici su analizirani u odnosu na hiperlipoproteinemije, kao i 
prema prisustvu vulnerabilnog i nevulnerabilnog aterosklerotskog plaka. Podaci su 
obrađeni odgovarajućim statističkim metodama. 
Hiperlipidemija je zastupljenija kod bolesnika sa DMT2 nego u kontrolnoj grupi 
(p<0.05). Vrednosti holesterola u krvi bile su značajno više (p<0.05) kod ispitanika sa 
DMT2 (5.74±2.69 vs. 4.82±1.11 mmol/L) kao i triglicerida (1.94±2.2 vs. 1.14±1.6 
mmol/L) (p<0.001). Srednje vrednosti glikemije u grupi ispitanika sa dijabetes 
melitusom tip 2 (10.54±3.75 mmol/L) i u kontrolnoj grupi (4.53±2.14mmol/L) 
značajno su različite (p<0.001). Vrednosti glikoziliranog hemoglobina HbA1c su 
značajno veće u grupi ispitanika  sa dijabetes melitusom (9.30±2.26%) u odnosu na 
kontrolnu grupu (4,98±0,05%). Srednje vrednosti kako sistolnog tako i dijastolnog 
krvnog pritiska bile su znatno više kod ispitanika sa DMT2 (149.55±29.27 mmHg, 
odnosno 87.92±17.58 mmHg) u odnosu na kontrolnu grupu (128.32±25.77 mmHg, a 
srednji dijastolni pritisak 79.11±9.51 mmHg). Plak je nađen kod 100% bolesnika sa 
dijabetesom, nasuprot 28.12% u kontrolnoj grupi. Vulnerabilni plak nađen je kod 
47.06% DMT2 bolesnika i 6.25% kontrolnih. Analiza Mann-Whitney-jevim testom 
pokazuje da je učestalosti pojave plaka i vulnerabilnog plaka značajno veća kod DMT2 
bolesnika (p<0.001). 
Hiperlipidemija, hipertenzija i dijabetes melitus tip 2 značajno su povezani sa 
aterosklerotskim promenama na krvnim sudovima. Ultrazvučno određivanje vulnera-
bilnosti plakova na karotidnim arterijama jedan je od značajnih kriterijuma za klasi-
fikaciju bolesnika sa visokim rizikom za  ishemijski moždani udar i pojavu DMT2.  Acta 
Medica Medianae 2012;51(3):29-37. 
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